Theresa Lawrence Ford

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

Richard Furie, Eric F. Morand, Ian N Bruce et al. · The Lancet Rheumatology · 2019 · 442 citations · Full text

Inflammation, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +10

Clinical practice guidelines for oral management of Sjögren disease

Domenick T. Zero, Michael T. Brennan, Troy E. Daniels et al. · The Journal of the American Dental Association · 2016 · 91 citations

Rheumatology, Sjögren’s Syndrome, Oral Hygiene +5

A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine

Michelle Sharp, Kristin M. Burkart, Mark Adelman et al. · CHEST Journal · 2020 · 36 citations · Full text

Critical Care Medicine, Burnout, Psychiatry +8

The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy

Jeffrey R. Curtis, Stacey S. Cofield, S. Louis Bridges et al. · Annals of Internal Medicine · 2021 · 36 citations

An Examination of Multiple Substance Use Between African American and Caucasian Female College Students

Octavia Madison-Colmore, Theresa Lawrence Ford, Vanessa Cooke et al. · Journal of Ethnicity in Substance Abuse · 2003 · 18 citations

Ethnicity, Substance Use, Drug Survey +17